Literature DB >> 19468777

Alternatives to animal experimentation for hormonal compounds research.

M Penza1, M Jeremic, C Montani, M Unkila, L Caimi, G Mazzoleni, Diego Di Lorenzo.   

Abstract

Alternatives to animal testing and the identification of reliable methods that may decrease the need for animals are currently the subject of intense investigation worldwide. Alternative testing procedures are particularly important for synthetic and natural chemicals that exert their biological actions through binding nuclear receptors, called nuclear receptors-interacting compounds (NR-ICs), for which research is increasingly emphasizing the limits of several models in the accurate estimation of the physiological consequences of exposure to these compounds. In particular, estrogen receptor interacting compounds (ER-ICs) have a great impact on human health from the therapeutic, nutritional, and toxicological point of view due to the highly permissive nature of the estrogen receptors towards a large number of natural and synthetic compounds. Similar to in vitro systems, recently generated animal models (e.g., animal models generated for the study of estrogen receptor ligands) may fulfill the 3R principles: refine, reduce, and replace. If used correctly, NR-regulated models, such as reporter mice, xenopus, or zebrafish, and models obtained by somatic gene transfer in reporter systems, combined with imaging technologies, may contribute to strongly decreasing the overall number of animals required for NR-IC testing and research. With these models, flexible and highly standardized parameters and reporter marker quantification can be obtained. Here, we highlight the need for the substitution of currently used testing models with more appropriate ones that can reproduce the features and reactivity of specific mammalian target tissue/organs. We consider the promotion of this advancement a research priority bearing scientific, economic, social, and ethical relevance.

Entities:  

Year:  2009        PMID: 19468777      PMCID: PMC2745740          DOI: 10.1007/s12263-009-0124-7

Source DB:  PubMed          Journal:  Genes Nutr        ISSN: 1555-8932            Impact factor:   5.523


  58 in total

1.  Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats.

Authors:  Q Qu; H Zheng; J Dahllund; A Laine; N Cockcroft; Z Peng; M Koskinen; K Hemminki; L Kangas; K Väänänen; P Härkönen
Journal:  Endocrinology       Date:  2000-02       Impact factor: 4.736

Review 2.  Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis.

Authors:  C Fiévet; B Staels
Journal:  Biochem Pharmacol       Date:  2008-12-03       Impact factor: 5.858

Review 3.  Molecular imaging, an innovative methodology for whole-body profiling of endocrine disrupter action.

Authors:  Diego Di Lorenzo; Gianpaolo Rando; Paolo Ciana; Adriana Maggi
Journal:  Toxicol Sci       Date:  2008-09-15       Impact factor: 4.849

4.  Transgenic zebrafish as sentinels for aquatic pollution.

Authors:  M J Carvan; T P Dalton; G W Stuart; D W Nebert
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

5.  Prolactin drives estrogen receptor-alpha-dependent ductal expansion and synergizes with transforming growth factor-alpha to induce mammary tumors in males.

Authors:  Lisa M Arendt; Linda A Schuler
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

Review 6.  Nuclear receptors as therapeutic targets in cholestatic liver diseases.

Authors:  Gernot Zollner; Michael Trauner
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

Review 7.  Peroxisome proliferator-activated receptor gamma pathway targeting in carcinogenesis: implications for chemoprevention.

Authors:  Frank Ondrey
Journal:  Clin Cancer Res       Date:  2009-01-01       Impact factor: 12.531

Review 8.  Multimodality imaging: novel pharmacological applications of reporter systems.

Authors:  A Stell; S Belcredito; B Ramachandran; A Biserni; G Rando; P Ciana; A Maggi
Journal:  Q J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 2.346

Review 9.  Atrazine interaction with estrogen expression systems.

Authors:  J Charles Eldridge; James T Stevens; Charles B Breckenridge
Journal:  Rev Environ Contam Toxicol       Date:  2008       Impact factor: 7.563

10.  Assessment of estrogenic endocrine-disrupting chemical actions in the brain using in vivo somatic gene transfer.

Authors:  Vance L Trudeau; Nathalie Turque; Sébastien Le Mével; Caroline Alliot; Natacha Gallant; Laurent Coen; Farzad Pakdel; Barbara Demeneix
Journal:  Environ Health Perspect       Date:  2005-03       Impact factor: 9.031

View more
  1 in total

1.  Upcyte® microvascular endothelial cells repopulate decellularized scaffold.

Authors:  Katharina Scheller; Iris Dally; Nadja Hartmann; Bernhard Münst; Joris Braspenning; Heike Walles
Journal:  Tissue Eng Part C Methods       Date:  2012-09-13       Impact factor: 3.056

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.